Tumor BRCA1/2 variant status was determined for 276 patients (251 complete reports with fully sequenced BRCA1 and BRCA2 genes, 25 indeterminate reports with at least one failed exon), of which 17.4% (48/276) had a pathogenic/likely pathogenic variant and 8.3% (23/276) carried a VUS. The gene discussed is BRCA2; the disease is neoplasm.